| Half-life | 12 hours |
| Clearance Route | renal |
| Active Metabolites | no |
| Notes | HCTZ short-acting; lisinopril long-acting. |
Severity: Moderate
Adverse Effects:
Cough, dizziness, hyperkalemia, hyponatremia
Contraindications:
Pregnancy, angioedema, anuria
Precautions:
Monitor K⁺/Na⁺; check renal function regularly